Cramer: Johnson & Johnson has 'mojo'

Not all stocks do, but CNBC's Jim Cramer said Tuesday Johnson & Johnson has "mojo."

"They came in jacked into the quarter, and they have mojo. I count 10 potential drugs of $1 billion in the pipe," Cramer said on "Squawk on the Street." "It's unbelievable."

Cramer made his remarks after the company reported better-than-expected earnings per share on revenues that were in line with expectations. The Dow component also raised its full-year guidance as it sees double-digit sales growth in the U.S.

Shares of Johnson & Johnson are up more than 9 percent year to date, and have gained 13 percent in the last 12 months. The stock also hit a new all-time intraday high of $113.95.

JNJ in the last year